Internal Medicine, Hematology & Oncology · Grand Rapids, MI
NPI
1952720906
Since 2014
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
145 Michigan St NE Ste 3100
Grand Rapids, MI, 49503
Phone (616) 954-9800
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
63,838 services
Medicare patients, 2024
415
Average age 71
Drug cost, 2024
$3.2M
1,723 prescriptions
Company payments, 2025
$723
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Haritha G Reddy was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 1,480 times for 43 patients. In total Haritha G Reddy billed 63,838 services in 158 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,480 | 43 | $0.09 | $130 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 560 | 18 | $0.70 | $392 |
| 96375 Injection Administration | Office | 334 | 57 | $10.83 | $3,617 |
| 36415 Venipuncture Blood Collection | Office | 331 | 88 | $8.65 | $2,863 |
| 85025 Blood Count | Office | 237 | 41 | $7.61 | $1,804 |
| 96413 Chemotherapy Administration | Office | 233 | 80 | $88.62 | $21K |
| 80053 Clinical Chemistry | Office | 221 | 40 | $10.34 | $2,286 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 217 | 39 | $4.47 | $969 |
| 99214 Office E&M - Established | Office | 201 | 150 | $80.09 | $16K |
| 99215 Office E&M - Established | Office | 192 | 93 | $129.02 | $25K |
| 83735 Clinical Chemistry | Office | 97 | 15 | $6.57 | $637 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 95 | 43 | $71.39 | $6,782 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 80 | 21 | $0.62 | $49.98 |
| 96417 Chemotherapy Administration | Office | 78 | 26 | $46.05 | $3,592 |
| 99233 Hospital E&M - Subsequent | Facility | 75 | 26 | $90.21 | $6,766 |
By year: 2022 $963K for 43,185 services; 2023 $980K for 47,373 services; 2024 $1.4M for 63,838 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 331 | 88 | $8.65 | $2,863 |
| 85025 Blood Count | 237 | 41 | $7.61 | $1,804 |
| 80053 Clinical Chemistry | 221 | 40 | $10.34 | $2,286 |
| 83735 Clinical Chemistry | 97 | 15 | $6.57 | $637 |
| 82306 Clinical Chemistry | 53 | 48 | $29.01 | $1,538 |
| 82565 Clinical Chemistry | 35 | 25 | $5.02 | $176 |
| 86704 Immunoassay | 11 | 11 | $11.81 | $130 |
| 86706 Immunoassay | 11 | 11 | $10.53 | $116 |
| 87340 Immunoassay | 11 | 11 | $10.12 | $111 |
Medicare prescription drug claims, 2024
In 2024, the drug Haritha G Reddy prescribed most often to Medicare patients was Anastrozole, with 708 prescriptions and refills. In total Haritha G Reddy wrote 1,723 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 708 | 1,997 | 242 | $23K |
| Tamoxifen Citrate Generic | 149 | 420 | 52 | $5,650 |
| Exemestane Generic | 130 | 288 | 49 | $20K |
| Letrozole Generic | 130 | 319 | 49 | $3,044 |
| Ibrance Palbociclib | 82 | 82 | 12 | $1.3M |
| Escitalopram Oxalate Generic | 67 | 103 | 16 | $577 |
| Kisqali Ribociclib Succinate | 56 | 57 | Under 11 | $979K |
| Prochlorperazine Maleate Generic | 49 | 49 | 35 | $552 |
| Olanzapine Generic | 31 | 31 | 19 | $136 |
| Verzenio Abemaciclib | 26 | 26 | Under 11 | $389K |
| Levothyroxine Sodium Generic | 25 | 32 | Under 11 | $179 |
| Nyvepria Pegfilgrastim-Apgf | 23 | 23 | Under 11 | $93K |
| Alendronate Sodium Generic | 22 | 62 | Under 11 | $454 |
| Gabapentin Generic | 22 | 33 | Under 11 | $263 |
| Neulasta Pegfilgrastim | 22 | 22 | Under 11 | $168K |
Brand drugs: 277 claims; generic drugs: 1,446 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Haritha G Reddy $723 ($723 in general payments such as food, travel and fees) from 14 companies. The largest payer was Novartis Pharmaceuticals Corporation with $209.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 11 | $209 |
| Merck Sharp & Dohme LLC MRK | 4 | $133 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $89.78 |
| Genzyme Corporation SNY | 2 | $47.78 |
| Celgene Corporation BMY | 2 | $45.76 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $33.31 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $28.55 |
| Amneal Pharmaceuticals LLC AMRX | 1 | $27.23 |
| Lilly USA, LLC LLY | 1 | $23.05 |
| Janssen Biotech, Inc. JNJ | 1 | $22.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.